CXCL1 and pancreatic adenocarcinoma: In addition, we found that 3 CpGs of CXCL1, 2 CpGs of CXCL2, 2 CpGs of CXCL3, 3 CpGs of CXCL4, 10 CpGs of CXCL5, 1 CpG of CXCL6, 1 CpG of CXCL7, 3 CpGs of CXCL12, 3 CpGs of CXCL14, and 5 CpGs of CXCL17 were significantly associated with prognosis in patients with PAAD (Table 6 and Figure S7).